Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

Clinical trial NCT00249795 · COMPLETED

Trial details

NCT number: NCT00249795
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Cardiovascular Disease

Start date: 2003-06-01
Primary completion: 2009-08-01
Enrollment: 9016

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.